The Office of Fair Trading report: a prescription for value-based drug pricing

被引:7
|
作者
Minhas, Rubin
Moon, James C.
机构
[1] CHD Clin Lead, Gillingham ME8 0NJ, Kent, England
[2] Heart Hosp, Dept Cardiol, London W1G 8PH, England
关键词
D O I
10.1258/jrsm.100.5.216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:216 / 218
页数:3
相关论文
共 50 条
  • [21] VALUE-BASED PRICING IN COLOMBIA: THE DEVIL IS IN THE DETAILS
    Gilardino, R.
    Guarin, D.
    Bustos Marquez, M. C.
    Forero, J. C.
    VALUE IN HEALTH, 2021, 24 : S152 - S152
  • [22] Current Policy and Practice for Value-Based Pricing
    Augustovski, Federico
    McClellan, Mark B.
    VALUE IN HEALTH, 2019, 22 (06) : S4 - S6
  • [23] Value-Based Pricing for Drugs Theme and Variations
    Kaltenboeck, Anna
    Bach, Peter B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (21): : 2165 - 2166
  • [24] The conceptualization of value-based pricing in industrial firms
    Liozu S.M.
    Hinterhuber A.
    Boland R.
    Perelli S.
    Journal of Revenue and Pricing Management, 2012, 11 (1) : 12 - 34
  • [25] Defining Value-Based Pricing of Drugs Reply
    Kaltenboeck, Anna
    Bach, Peter B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (16): : 1710 - 1711
  • [26] Value-based pricing special issue: Editorial
    Liozu S.M.
    Journal of Revenue and Pricing Management, 2017, 16 (1) : 1 - 3
  • [27] Value-Based Pricing: L'Enfant Terrible?
    Garner, Sarah
    Rintoul, Andrew
    Hill, Suzanne R.
    PHARMACOECONOMICS, 2018, 36 (01) : 5 - +
  • [28] Value-based medicine pricing: NICE work?
    Webb, David J.
    LANCET, 2011, 377 (9777): : 1552 - 1553
  • [29] Value-Based Pricing: L’Enfant Terrible?
    Sarah Garner
    Andrew Rintoul
    Suzanne R. Hill
    PharmacoEconomics, 2018, 36 : 5 - 6
  • [30] VALUE-BASED PRICING IN SINGAPORE: IS IT A RACE TO THE BOTTOM?
    Ghosh, W.
    Bose, R.
    Viswambaram, A.
    Brooks-Rooney, C.
    VALUE IN HEALTH, 2018, 21 : S9 - S9